ResMed Revenue 2006-2019 | RMD

ResMed annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • ResMed revenue for the quarter ending March 31, 2019 was $0.662B, a 11.93% increase year-over-year.
  • ResMed revenue for the twelve months ending March 31, 2019 was $2.525B, a 11.08% increase year-over-year.
  • ResMed annual revenue for 2018 was $2.34B, a 13.23% increase from 2017.
  • ResMed annual revenue for 2017 was $2.067B, a 12.4% increase from 2016.
  • ResMed annual revenue for 2016 was $1.839B, a 9.52% increase from 2015.
ResMed Annual Revenue
(Millions of US $)
2018 $2,340
2017 $2,067
2016 $1,839
2015 $1,679
2014 $1,555
2013 $1,514
2012 $1,369
2011 $1,243
2010 $1,092
2009 $921
2008 $835
2007 $716
2006 $607
2005 $426
ResMed Quarterly Revenue
(Millions of US $)
Q3 2019 $662
Q2 2018 $651
Q1 2018 $588
Q4 2018 $624
Q3 2018 $592
Q2 2017 $601
Q1 2017 $524
Q4 2017 $557
Q3 2017 $514
Q2 2016 $530
Q1 2016 $465
Q4 2016 $519
Q3 2016 $454
Q2 2015 $455
Q1 2015 $412
Q4 2015 $453
Q3 2015 $422
Q2 2014 $423
Q1 2014 $380
Q4 2014 $415
Q3 2014 $398
Q2 2013 $384
Q1 2013 $358
Q4 2013 $415
Q3 2013 $384
Q2 2012 $377
Q1 2012 $340
Q4 2012 $372
Q3 2012 $349
Q2 2011 $333
Q1 2011 $315
Q4 2011 $342
Q3 2011 $313
Q2 2010 $306
Q1 2010 $282
Q4 2010 $292
Q3 2010 $279
Q2 2009 $275
Q1 2009 $247
Q4 2009 $252
Q3 2009 $228
Q2 2008 $223
Q1 2008 $218
Q4 2008 $235
Q3 2008 $212
Q2 2007 $203
Q1 2007 $186
Q4 2007 $191
Q3 2007 $183
Q2 2006 $178
Q1 2006 $164
Q4 2006 $171
Q3 2006 $162
Q2 2005 $146
Q1 2005 $127
Q4 2005 $125
Q3 2005 $108
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.745B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.856B 28.70
Medtronic (MDT) Ireland $133.874B 19.12
Stryker (SYK) United States $76.669B 27.36
Boston Scientific (BSX) United States $59.033B 28.30
Baxter (BAX) United States $41.839B 26.37
EssilorLuxottica Societe Anonyme (ESLOY) France $29.060B 0.00
Coloplast (CLPBY) Denmark $25.618B 40.90
Zimmer Biomet Holdings (ZBH) United States $24.965B 16.04
Lonza Group Ag (LZAGY) Switzerland $24.947B 0.00
Terumo (TRUMY) Japan $23.393B 26.90
Smith & Nephew SNATS (SNN) United Kingdom $19.274B 0.00
Canopy Growth (CGC) Canada $12.161B 0.00
Sunny Optical Technology (SNPTF) China $12.027B 0.00
Bio-Rad Laboratories (BIO) United States $9.308B 49.34
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Insulet (PODD) United States $7.203B 524.78
Aurora Cannabis (ACB) Canada $7.109B 70.10
Perrigo (PRGO) Ireland $7.004B 11.84
Hill-Rom Holdings (HRC) United States $6.993B 21.20
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.325B 51.63
ICU Medical (ICUI) United States $5.135B 30.64
GW Pharmaceuticals (GWPH) United Kingdom $5.057B 0.00
Neogen (NEOG) United States $3.349B 54.45
NuVasive (NUVA) United States $2.982B 24.36
Hutchison China MediTech (HCM) China $2.925B 0.00
Agios Pharmaceuticals (AGIO) United States $2.711B 0.00
National Vision Holdings (EYE) United States $2.420B 51.57
Quidel (QDEL) United States $2.309B 23.96
Cardiovascular Systems (CSII) United States $1.598B 917.80
Aphria (APHA) $1.579B 0.00
Phibro Animal Health (PAHC) United States $1.229B 18.41
AtriCure (ATRC) United States $1.218B 0.00
VAREX IMAGING (VREX) United States $1.187B 25.19
Lantheus Holdings (LNTH) United States $1.089B 28.93
NanoString Technologies (NSTG) United States $1.056B 0.00
PetIQ (PETQ) United States $0.994B 24.14
MacroGenics (MGNX) United States $0.777B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.765B 21.47
Cerus (CERS) United States $0.758B 0.00
Quanterix (QTRX) United States $0.753B 0.00
Omeros (OMER) United States $0.750B 0.00
TG Therapeutics (TGTX) United States $0.698B 0.00
LeMaitre Vascular (LMAT) United States $0.572B 27.71
Surmodics (SRDX) United States $0.543B 78.88
OraSure Technologies (OSUR) United States $0.531B 24.43
Meridian Bioscience (VIVO) United States $0.476B 14.56
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.404B 0.00
Vapotherm (VAPO) United States $0.345B 0.00
Utah Medical Products (UTMD) United States $0.320B 22.13
BioLife Solutions (BLFS) United States $0.304B 95.24
Zynex (ZYXI) United States $0.250B 25.67
Bovie Medical (APYX) United States $0.236B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.198B 4.20
Chimerix (CMRX) United States $0.188B 0.00
United Health Products (UEEC) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.170B 0.00
Female Health (VERU) United States $0.146B 0.00
Fonar (FONR) United States $0.139B 7.33
Chembio Diagnostics (CEMI) United States $0.098B 0.00
United-Guardian (UG) United States $0.094B 20.65
InfuSystems Holdings (INFU) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.075B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 20.75
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
MRI INTERVENTNS (MRIC) United States $0.052B 0.00